Results 41 to 50 of about 269 (119)

S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 4, Page 605-621, April 2024.
Zusammenfassung Die vorliegende aktualisierte S2k‐Leitlinie befasst sich mit der Diagnostik und der Therapie der zirkumskripten Sklerodermie (ZS). Diese umfasst ein Spektrum sklerotischer Erkrankungen der Haut mit, je nach Subtyp und Lokalisation, möglicher Beteiligung von hautnahen Strukturen wie Fettgewebe, Muskulatur, Gelenke und Knochen. Ein Befall
Alexander Kreuter   +12 more
wiley   +1 more source

Diagnostic and treatment strategies of dermatologists for treating morphea in Hungary [PDF]

open access: yes, 2018
Localized scleroderma is an uncommon disease, only infrequently encountered by dermatologists in private practices or even in larger academic centers. Because of its rarity, current treatment guidelines are mostly based on low-level clinical evidence and
Bernadett Hidvégi, Gabor Bali
core   +1 more source

Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast

open access: yesClinical, Cosmetic and Investigational Dermatology, 2018
Rowland Noakes Queensland Institute of Dermatology, Greenslopes Private Hospital Campus, Greenslopes, QLD, Australia Background: Scleroderma is traditionally managed with immunomodulatory agents such as methotrexate, mycophenolate mofetil and ...
Noakes R
doaj  

Systematic Review of Health‐Related Quality of Life Impact in Juvenile Localized Scleroderma

open access: yesArthritis Care &Research, Volume 76, Issue 3, Page 340-349, March 2024.
Objective The prevalence and types of psychosocial complications of juvenile localized scleroderma (JLS), also known as morphea, an inflammatory and sclerosing disease involving the skin, fascia, muscle, and bone, are poorly understood. Methods We performed a systematic review of literature published between 2000 and 2020 in PubMed, EMBASE, the ...
Luis F. Sanchez‐Espino   +5 more
wiley   +1 more source

Novel multispectral imaging to predict disease progression in pediatric morphea

open access: yesPediatric Dermatology, Volume 41, Issue 2, Page 229-233, March/April 2024.
Abstract Background Morphea, or localized scleroderma, is an inflammatory, fibrosing skin disorder that can be progressive and debilitating. Infrared thermography frequently has false positive results. The aim of this study was to assess the ability of multispectral imaging to predict disease progression in children with morphea.
Cathal O'Connor   +4 more
wiley   +1 more source

Global research status of localised scleroderma reported over the period 1993–2022: A 30‐year bibliometric analysis

open access: yesInternational Wound Journal, Volume 21, Issue 1, January 2024.
Abstract Localised scleroderma predominantly affects the skin with an unknown aetiology. Despite its clinical importance, no comprehensive bibliometric analysis has been conducted to assess the existing research landscape and future prospects for localised scleroderma. The articles related to localised scleroderma were retrieved from the WoSCC database
Zi‐Ming Li   +5 more
wiley   +1 more source

Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre [PDF]

open access: yes, 2020
Background: Linear morphoea is a severe morphoea subtype associated with extracutaneous manifestations, potentially permanent disfigurement and functional impairment.
Denton, CP   +3 more
core  

Quality of life with scleroderma [PDF]

open access: yes, 2020
This bachelor thesis deals with the evaluation of the quality of life with scleroderma, a chronic autoimmune disease. The work is focused on determining the health-related quality of life of patients with localized and systemic scleroderma.
Bendlová, Iva
core   +1 more source

Regenerative treatments for scleroderma in cutaneous manifestations of the face:a systematic review [PDF]

open access: yes
OBJECTIVES: Scleroderma is a heterogeneous chronic autoimmune disease affecting connective tissue, characterised by chronic inflammation and fibrosis, particularly affecting internal organs and skin.
Dijkstra, Pieter U   +8 more
core   +1 more source

Morphea: clinical subtypes and management in a tertiary care hospital: A 12 years retrospective study [PDF]

open access: yes
Antecedentes: la morfea es una enfermedad inflamatoria que afecta de forma primaria a la piel y los tejidos subyacentes, y produce como consecuencia la esclerosis de los mismos.
Bendjuia, Gabriela   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy